NCT03741829View on ClinicalTrials.gov

TS Overexpression in SCLC: Mechanism and Therapeutic Targeting

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions
Small Cell Lung Cancer
Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT03741829 - TS Overexpression in SCLC: Mechanism and Therapeutic Targeting | Biotech Hunter | Biotech Hunter